Dimensional Fund Advisors’s ALX Oncology ALXO Stock Holding History

Dimensional Fund Advisors’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$132K	Buy	+95,158	New	+$184K	﹤0.01%	3115
2025 Q1	–	Sell	-26,233	Closed	-$43.8K	–	3323
2024 Q4	$43.8K	Sell	26,233 -11,413	-30%	-$17.5K	﹤0.01%	3301
2024 Q3	$68.8K	Buy	37,646 +3,103	+9%	+$11.5K	﹤0.01%	3268
2024 Q2	$208K	Sell	34,543 -15,798	-31%	-$194K	﹤0.01%	3158
2024 Q1	$561K	Sell	50,341 -83,881	-62%	-$1.18M	﹤0.01%	3026
2023 Q4	$2M	Sell	134,222 -517	-0.4%	-$4.9K	﹤0.01%	2791
2023 Q3	$647K	Buy	134,739 +45,367	+51%	+$246K	﹤0.01%	3011
2023 Q2	$671K	Sell	89,372 -3,040	-3%	-$19.9K	﹤0.01%	3003
2023 Q1	$418K	Buy	+92,412	New	+$700K	﹤0.01%	3067
2022 Q3	$636K	Buy	+66,473	New	+$775K	﹤0.01%	2989

Other funds holding ALXO

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

JSF Financial Los Angeles, California $655M AUM 20.11% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Lido Advisors Los Angeles, California $39.1B AUM 20.96% 1-Year Est. Return

Dimensional Fund Advisors's ALXO Position: Q3 2026 in Review

Dimensional Fund Advisors opened a new position in ALX Oncology (ALXO) in Q3 2026: 95,158 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #3115 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in ALXO as recently as Q4 2024.

Dimensional Fund Advisors first reported a position in ALXO in Q3 2022 and has held it in 10 quarters since. The position peaked at $2M in Q4 2023. 26 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

Dimensional Fund Advisors held 95,158 shares of ALX Oncology worth $132K as of Q3 2026.
ALX Oncology was a new Dimensional Fund Advisors position in Q3 2026.
ALX Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3115 holding.
Dimensional Fund Advisors first reported a position in ALX Oncology in Q3 2022 and has held it in 10 quarters since.
Dimensional Fund Advisors's ALX Oncology position peaked at $2M in Q4 2023.
26 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.